000 01421 a2200409 4500
005 20250515091937.0
264 0 _c20080117
008 200801s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD005500.pub2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAshcroft, D M
245 0 0 _aTopical pimecrolimus for eczema.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_cOct 2007
300 _aCD005500 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAdministration, Topical
650 0 4 _aAdolescent
650 0 4 _aAdrenal Cortex Hormones
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDermatologic Agents
_xadministration & dosage
650 0 4 _aEczema
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aInfant
650 0 4 _aQuality of Life
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTacrolimus
_xadministration & dosage
700 1 _aChen, L-C
700 1 _aGarside, R
700 1 _aStein, K
700 1 _aWilliams, H C
773 0 _tThe Cochrane database of systematic reviews
_gno. 4
_gp. CD005500
856 4 0 _uhttps://doi.org/10.1002/14651858.CD005500.pub2
_zAvailable from publisher's website
999 _c17464045
_d17464045